David Campbell
Director/Board Member at SYNAIRGEN PLC
Net worth: 25 739 $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
William Rosenberg | M | - |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | 21 years |
Phillip Monk | M | 55 | 18 years | |
Amanda Radford | F | 53 | 2 years | |
Stephen Holgate | M | 77 | 21 years | |
Richard Marsden | M | 57 | 21 years | |
Joseph Colliver | M | 43 | 1 years | |
Brenda Reynolds | M | - |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | - |
Helen Gearing | F | - | 3 years | |
Gareth Walters | M | - | 3 years | |
Marcin Mankowski | M | - | 1 years | |
Richard Francis | M | - | 3 years | |
Jody Brooks | F | - | 20 years | |
Michael Underwood | M | - |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | 10 years |
Brooke Clarke | F | - | 3 years | |
Simon Shaw | M | 59 | 21 years | |
John Tite | M | - |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | 15 years |
Simon Holden | M | 48 | - | |
Felicity Gabbay | M | 72 | 2 years | |
Richard Hennings | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
John Ward | M | 63 | 19 years | |
Mike Whelan | M | - |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | - |
Theodora Caroline Harold | F | 50 | 1 years | |
Iain Peter Murray Buchanan | M | 72 | 12 years | |
Peter Woodford | M | 76 |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | - |
Paul Hugh Anthony Clegg | M | 64 | 10 years | |
Susan Margaret Sundström | F | - | 6 years | |
Brent Bartlett | M | - |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | - |
Vic Laville | M | - |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | - |
Statistics
Country | Connections | % of total |
---|---|---|
United Kingdom | 28 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Campbell
- Personal Network